Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|October 3, 2019
Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza DrugsSonja C J H Chua, Hui Qing Tan, David Engelberg, et al.
Iscience|July 13, 2026
Erk inhibitors intercept Erk-mediated negative feedback while imposing cell-cycle arrest and activating p38Merav Darash-Yahana, Nadine Soudah, Alexey Baskin, et al.
Pharmacology & Therapeutics|February 5, 2022
Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?C K Matthew Heng, Nechama Gilad, Ilona Darlyuk-Saadon, et al.
The Journal of Biological Chemistry|April 13, 2025
All intrinsically active Erk1/2 mutants autophosphorylate threonine207/188, a plausible regulator of the TEY motif phosphorylationAlexey Baskin, Nadine Soudah, Nechama Gilad, et al.
The Journal of Biological Chemistry|July 10, 2014
The p38β mitogen-activated protein kinase possesses an intrinsic autophosphorylation activity, generated by a short region composed of the α-G helix and MAPK insertJonah Beenstock, Sheer Ben-Yehuda, Dganit Melamed, et al.
Molecular Pharmacology|July 19, 2006
JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeastYael Friedmann, Anat Shriki, Estelle R Bennett, et al.
Molecular and Cellular Biology|March 16, 2016
p38β Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues Thr241 and Ser261Jonah Beenstock, Dganit Melamed, Navit Mooshayef, et al.
Genetics|November 20, 2019
An Activating Mutation in ERK Causes Hyperplastic Tumors in a scribble Mutant Tissue in DrosophilaTatyana Kushnir, Shaked Bar-Cohen, Navit Mooshayef, et al.
Molecular Biology of the Cell|July 15, 2016
Variants of the yeast MAPK Mpk1 are fully functional independently of activation loop phosphorylationTal Goshen-Lago, Anat Goldberg-Carp, Dganit Melamed, et al.
The Journal of Biological Chemistry|July 20, 2023
A conserved arginine within the αC-helix of Erk1/2 is a latch of autoactivation and of oncogenic capabilitiesNadine Soudah, Alexey Baskin, Karin Smorodinsky-Atias, et al.
Pageof 6